Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Benowitz

Showing results (51-60 of 291) with videos related to

Pageof 30
Sort By:
Cardiovascular Drugs and Therapy|June 1, 1993
Clinical significance of genetic influences on cardiovascular drug metabolismL Arcavi, N L Benowitz
British Journal of Clinical Pharmacology|February 13, 2001
Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smokingN L Benowitz, P Jacob
Clinical Pharmacology and Therapeutics|April 1, 1984
Daily intake of nicotine during cigarette smokingN L Benowitz, P Jacob
Clinical Pharmacology and Therapeutics|August 1, 1984
Nicotine and carbon monoxide intake from high- and low-yield cigarettesN L Benowitz, P Jacob
Clinical Pharmacology and Therapeutics|March 1, 1993
Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokersN L Benowitz, P Jacob
Drug Safety|November 1, 1991
Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipineP D Pearigen, N L Benowitz
The New England Journal of Medicine|December 16, 2000
Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloidsC A Haller, N L Benowitz
American Journal of Epidemiology|October 1, 1994
Re: "Inconsistent associations of caffeine-containing beverages with blood pressure and with lipoproteins: the CARDIA Study"D S Sharp, N L Benowitz
Journal of Clinical Pharmacology|August 1, 1981
Cardiovascular and metabolic considerations in prolonged cannabinoid administration in manN L Benowitz, R T Jones
Psychopharmacology|January 1, 1980
An abstinence syndrome following chronic administration of delta-9-terahydrocannabinol in rhesus monkeysA B Fredericks, N L Benowitz
Pageof 30

Showing results (51-60 of 291) with videos related to

Sort By:
Pageof 30
Cardiovascular Drugs and Therapy|June 1, 1993
Clinical significance of genetic influences on cardiovascular drug metabolismL Arcavi, N L Benowitz
British Journal of Clinical Pharmacology|February 13, 2001
Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smokingN L Benowitz, P Jacob
Clinical Pharmacology and Therapeutics|April 1, 1984
Daily intake of nicotine during cigarette smokingN L Benowitz, P Jacob
Clinical Pharmacology and Therapeutics|August 1, 1984
Nicotine and carbon monoxide intake from high- and low-yield cigarettesN L Benowitz, P Jacob
Clinical Pharmacology and Therapeutics|March 1, 1993
Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokersN L Benowitz, P Jacob
Drug Safety|November 1, 1991
Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipineP D Pearigen, N L Benowitz
The New England Journal of Medicine|December 16, 2000
Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloidsC A Haller, N L Benowitz
American Journal of Epidemiology|October 1, 1994
Re: "Inconsistent associations of caffeine-containing beverages with blood pressure and with lipoproteins: the CARDIA Study"D S Sharp, N L Benowitz
Journal of Clinical Pharmacology|August 1, 1981
Cardiovascular and metabolic considerations in prolonged cannabinoid administration in manN L Benowitz, R T Jones
Psychopharmacology|January 1, 1980
An abstinence syndrome following chronic administration of delta-9-terahydrocannabinol in rhesus monkeysA B Fredericks, N L Benowitz
Pageof 30